I see what your saying and in all reality that can go both ways. I have seen where buys show up as sells as well. Hell I have seen my own buy orders cross the tape as a sell. Either way its up to the market right now. I will say I do like the fact that insiders filed form 4's recently. I still say this one is going higher. Chart aside Teva just upped their ownership they just did some financing to give them a nice chunk of cash. They have no real debt and they have many irons in the fire on the pipeline. So weather it goes up or down tomorrow I think this one is going to see a nice move higher. We get more milestone payment soon and this one will see a nice move up. The CEO already said they expect to see more milestone payments from Teva coming to them in the second half of 2013. Also per their website RX-5902 looks to have some nice interest. This one looks cheap to me. I am not huge on Biotech the only two I have really liked for years has been ARIA and GTXI. After reading up on this one for awhile I think this one looks cheap here. I guess time will tell so good luck to us both.
RX-5902: Rexahn has filed the IND for RX-5902 and will be initiating a Phase I clinical trial in the second quarter of 2013. We are actively seeking partnership/collaboration with other pharmaceutical companies to license-out or co-develop the program. We are in multiple discussions with companies for partnership.
News 
Market Data 
Discover 
AI
